Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study

Maturitas(2026)10.1016/j.maturitas.2026.108886Source: DataRank Database

Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study is a research paper published in Maturitas (2026). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 6.66)OA: hybridTopics (48)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (26)

Marleen M.H.J. van Gelder,Rosella P.M.G. Hermens,Majke H.D. van Bommel,Mirjam J.A. Apperloo,Marieke Arts-de Jong

Live enrichment

PubMed:41730824 OpenAlex:https://openalex.org/W7130936891

Dutch Cancer Society

Grant: KUN2014\u20137187

FWCI

6.66

Citation Percentile

0.9%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://www.maturitas.org/article/S0378-5122(26)00063-0/pdf

HYBRIDhttps://www.maturitas.org/article/S0378-5122(26)00063-0/pdf

publisherhttps://www.maturitas.org/article/S0378-5122(26)00063-0/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0378512226000630?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0378512226000630?httpAccept=text/plain

Fields of Study

BRCA gene mutations in cancerCancer Risks and FactorsOvarian cancer diagnosis and treatmentMedicineAdultFemaleHumansMiddle AgedBRCA1 ProteinBRCA2 ProteinCardiovascular DiseasesFallopian Tube NeoplasmsHeart Disease Risk FactorsHormone Replacement TherapyLongitudinal StudiesOvarian NeoplasmsOvariectomyRisk FactorsSalpingectomySalpingo-oophorectomy

MeSH Terms

Salpingo-oophorectomyHeart Disease Risk FactorsAdultCardiovascular DiseasesFallopian Tube NeoplasmsFemaleHumansLongitudinal StudiesMiddle AgedOvarian NeoplasmsOvariectomyRisk FactorsEstrogen Replacement TherapyBRCA1 ProteinHormone Replacement TherapyGenes, BRCA2BRCA2 ProteinSalpingectomy

Keywords

Reduction (mathematics)CancerRisk factorRisk assessmentOvarian cancerPreventionBRCA1BRCA2Cardiovascular RiskHormonal Replacement Therapy

Sustainable Development Goals

SDG 0: Good health and well-being

Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study

FAIR Checklist

DataRank Breakdown

Authors (26)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)